SCHEMBL2812347

SCHEMBL2812347

CC(C)(C)N(C(=O)O)C1(C(=O)NCc2ccc(Nc3ccccc3C(F)(F)F)cc2)CCOC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
GAA P10253 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
POLB P06746 3/20 0.37
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
THRB P10828 1/20 0.36
RAB9A P51151 1/20 0.36
NOX1 Q9Y5S8 1/20 0.36
HTT P42858 2/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RECQL P46063 1/20 0.35
EPHX2 P34913 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
NAMPT P43490 2/20 0.34
P2RX7 Q99572 1/20 0.34
MT-CO2 P00403 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812349 1.00 ALDH1A1 (0.37) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL2805756 0.81 ALDH1A1 (0.41) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL13159664 0.81 ALDH1A1 (0.39) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL186501 0.79 ALDH1A1 (0.40) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL2805680 0.79 ALDH1A1 (0.40) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL2812345 0.78 POLB (0.43) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL2805090 0.74 ALDH1A1 (0.43) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL2811321 0.74 CTDSP1 (0.39) ALDH1A1MEN1KMT2APOLBKDM4E
SCHEMBL184945 0.74 MT-CO2 (0.43) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL2809237 0.74 GAA (0.44) ALDH1A1GAAMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131075-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-23 US disclosed
US-20100240669-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131075-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 ALDH1A1 1000/4885GAA 1561/4885MEN1 314/4885
US-20100240669-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 ALDH1A1 1000/4885GAA 1561/4885MEN1 314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.